Skip Navigation

Cardiovascular Research 2002 53(1):175-180; doi:10.1016/S0008-6363(01)00435-7
© 2002 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Teoh, L.K.K.
Right arrow Articles by Yellon, D.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Teoh, L.K.K.
Right arrow Articles by Yellon, D.M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2001, European Society of Cardiology

The effect of preconditioning (ischemic and pharmacological) on myocardial necrosis following coronary artery bypass graft surgery

L.K.K. Teoha, R. Grantb, J.A. Hulfb, W.B. Pugsleyb,c and D.M. Yellona,*

aThe Hatter Institute for Cardiovascular Studies, Department of Cardiology, UCL Hospitals, Grafton Way, London WC1E 6DB, UK
bThe Department of Cardiothoracic Surgery, The Middlesex Hospital, Mortimer Street, London W1N 8AA, UK
cThe Sussex Cardiac Centre, Royal Sussex County Hospital, Brighton, UK

* Corresponding author. Tel.: +44-20-7380-9888; fax: +44-20-7388-5095 hatter-institute{at}ucl.ac.uk

Objectives: Ischemic preconditioning is known to protect the human heart from ischemic injury during coronary artery bypass graft (CABG) surgery but is not practised routinely. Adenosine A1 receptor agonists may confer protection in this setting by mimicking preconditioning. The aim of this study was to compare preconditioning, by ischemia or an adenosine A1 receptor agonist (GR79236X), with an established method of myocardial protection in CABG, namely intermittent cross-clamp fibrillation. Methods: In this prospective double-blind study, 30 CABG patients were randomised to receive: (a) intermittent cross-clamp fibrillation (control), (b) pharmacological preconditioning (GR79236X), or (c) ischemic preconditioning (two 3-min periods of ischemia, each followed by 2 min of reperfusion). Surgery was performed under standardised conditions by one surgeon (WBP). The primary endpoint was cardiac troponin T release. Results: Mean cardiopulmonary bypass time was 91±11.6 (S.D.) min. Mean ischemic time was 33±5.5 (S.D.) min with no inter-group difference. Mean troponin T at 72 h was highest in the control group (1.32±0.99 (S.D.) µg/l), similar in the GR79236X group (1.22±1.22 (S.D.) µg/l; P=0.85) and significantly reduced in the ischemic preconditioning group (0.58±0.40 (S.D.) µg/l; P=0.04). Conclusions: Ischemic preconditioning is superior to the other techniques at limiting myocardial necrosis during CABG. Pharmacological preconditioning may confer some benefit but this was not statistically shown using a specific adenosine A1 agonist (GR79236X).

KEYWORDS Adenosine; Cardiovascular surgery; Preconditioning


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.